Hookipa Biotech, a startup biotech company specialized in developing new generation vaccines. Founded in July 2011, in Austria, Hookipa Biotech has developed a proprietary technology platform, VaxwaveTM, dedicated to genetic vaccines for the prophylactic and therapeutic treatment of viral diseases. VaxwaveTM introduces a new approach to vaccination by providing long lasting and potent stimulation of both cellular and humoral immunity; the platform has been validated in different disease models. The company will use the Series A funds to advance its lead product HB101 through pre-clinical development and a Phase I proof of concept study, and to further industrialize and validate the VaxwaveTM technology.
Current Team (3)Update
Funding Rounds (2) - $35.3MUpdate
TVI's mission is to identify, help create and support the development of therapeutic...
BioMedPartners is one of the leading European venture capital firms providing private equity and...
Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life...
Venture Capital Firm
Sofinnova Partners is an independent venture capital firm based in Paris, France. For over 35...